3 ms·
FDA could give overriding authority to oblige manufacturers to provide a sample to the generic manufacturers for drugs older than <x>. Of course this is bad for
by AstralStorm 9y ago
FDA could give overriding authority to oblige manufacturers to provide a sample to the generic manufacturers for drugs older than <x>. Of course this is bad for business.
Alternatively the generic manufacturer would have to run a phase 1 and 2 trial. (Skip requirement for phase 3)
Expensive, but much less than full R&D.
- refurb 9y agoMy understanding is that's the plan. Right now branded drug companies say "REMS regulations mean we can't provide a drug for anyone but a patient." All the gov't has to do is say "no, if a generic company requests a sample you can provide de it without violating REMS regulations".